Pharmaceutical Executive
October 11, 2005
0
0
A look at what the advent of generic antiretroviral drugs could mean for the industry.
October 11, 2005
0
0
Experts are thrilled about the development of a new iron chelation drug that could be taken orally, changing the lives of patients who need chronic blood transfusions.
October 11, 2005
0
0
ABthrax takes advantage of new knowledge about anthrax to fight the bacteria’s lethal toxin.